Teriflunomide Mylan Eiropas Savienība - latviešu - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomīds - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Klertis 12,5 mg cietās kapsulas Latvija - latviešu - Zāļu valsts aģentūra

klertis 12,5 mg cietās kapsulas

egis pharmaceuticals plc, hungary - sunitinibs - kapsula, cietā - 12,5 mg

Klertis 25 mg cietās kapsulas Latvija - latviešu - Zāļu valsts aģentūra

klertis 25 mg cietās kapsulas

egis pharmaceuticals plc, hungary - sunitinibs - kapsula, cietā - 25 mg